Active	Status	Sponsor type	Region	Phase	Filter
1 Active 2 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   - « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
MSV-allo / Citospin
MSV_LE, NCT03673748 / 2017-000391-28: Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells	Recruiting	2	20	Europe	Mesenchymal stem cells (MSC), MSV, GMP-compliant MSC manufactured by IBGM in Valladolid, Placebo, Saline solution	Red de Terapia Celular, Hospital del Río Hortega, Hospital Clínico Universitario de Valladolid, University of Valladolid, Citospin	Lupus Nephritis, Lupus Erythematosus	07/25	07/26

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
MSV-allo / Citospin
MSV_LE, NCT03673748 / 2017-000391-28: Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells	Recruiting	2	20	Europe	Mesenchymal stem cells (MSC), MSV, GMP-compliant MSC manufactured by IBGM in Valladolid, Placebo, Saline solution	Red de Terapia Celular, Hospital del Río Hortega, Hospital Clínico Universitario de Valladolid, University of Valladolid, Citospin	Lupus Nephritis, Lupus Erythematosus	07/25	07/26